Nutex Health Responds to Short Seller Report
Rhea-AI Summary
Nutex Health (NASDAQ: NUTX), a physician-led healthcare system operating 24 micro hospitals and HOPDs across 11 states, has issued a formal response to a recent short seller report. The company strongly refutes allegations regarding its collection process, stating that the report contains misrepresentations and demonstrates a misunderstanding of their business model.
Nutex Health emphasizes its robust internal process for coding, billing, and handling medical claims through independent dispute resolution when necessary. The company plans to provide additional updates in its upcoming Q2 2025 earnings release and Form 10-Q, expected by August 14, 2025.
Positive
- Company maintains a robust internal process for coding, billing, and claims resolution
- Company will provide transparency through upcoming Q2 2025 earnings release
Negative
- Company faces allegations from short sellers regarding collection processes
- Stock price likely affected by short seller attack
News Market Reaction
On the day this news was published, NUTX gained 3.07%, reflecting a moderate positive market reaction. Argus tracked a trough of -11.8% from its starting point during tracking. Our momentum scanner triggered 14 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $17M to the company's valuation, bringing the market cap to $561M at that time.
Data tracked by StockTitan Argus on the day of publication.
The Company is aware of the allegations made in a recent short seller report that attempts to call into question the Company's collection process. As previously disclosed, Nutex Health has developed a robust internal process to code, bill and, if necessary after a federally mandated negotiation period, submit eligible medical claims to independent dispute resolution.
The Company strongly disagrees with the allegations in the report and believes it is without merit. Further, the Company believes the report contains misrepresentations and conveys a misunderstanding of Nutex Health's business.
Nutex Health expects to provide related updates in its upcoming earnings release and Form 10-Q for the second quarter of 2025 due on or before August 14, 2025.
About Nutex Health Inc.
Headquartered in
The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 24 facilities in 11 states.
The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups.
Forward-Looking Statements
Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act , economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2024, under the heading "Risk Factors" in Part II, Item IA thereof, and the risk factors and other cautionary statements contained in our other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.
View original content:https://www.prnewswire.com/news-releases/nutex-health-responds-to-short-seller-report-302512578.html
SOURCE Nutex Health, Inc.
FAQ
What allegations did short sellers make against Nutex Health (NASDAQ: NUTX)?
How did Nutex Health (NUTX) respond to the short seller report in July 2025?
When will Nutex Health (NUTX) provide more details about the short seller allegations?
How many facilities does Nutex Health operate in 2025?
What is Nutex Health's (NUTX) current business model?
